# 4D Molecular (FDMT) — Analyst Forecast

FDMT · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/fdmt/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 11 | 1 | 0 | 12 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $20.00 | $30.20 | $37.00 | 5 |

Last price $12.87 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 6, 2026 | Chardan Capital | Maintained | Buy | $25.00 |
| Sep 29, 2026 | B of A Securities | Maintained | Buy | $33.00 |
| Sep 14, 2026 | Cantor Fitzgerald | Upgraded | Neutral → Overweight | $20.00 |
| Jul 31, 2026 | B. Riley Securities | Initiated Coverage | Buy | $37.00 |
| Jul 20, 2026 | HC Wainwright & Co. | Maintained | Buy | $36.00 |
| Mar 30, 2026 | Jefferies | Initiated Coverage | Buy | $21.00 |
| Mar 20, 2026 | HC Wainwright & Co. | Maintained | Buy | $36.00 |
| Mar 19, 2026 | Chardan Capital | Maintained | Buy | $26.00 |
| Mar 19, 2026 | RBC Capital | Maintained | Outperform | $35.00 |
| Jan 28, 2026 | Barclays | Initiated Coverage | Overweight | $33.00 |
| Dec 18, 2025 | Chardan Capital | Maintained | Buy | $26.00 |
| Nov 11, 2025 | Chardan Capital | Maintained | Buy | $26.00 |
| Nov 11, 2025 | Barclays | Maintained | Overweight | $33.00 |
| Nov 11, 2025 | RBC Capital | Maintained | Outperform | $32.00 |
| Oct 21, 2025 | RBC Capital | Maintained | Outperform | $26.00 |
| Aug 12, 2025 | Chardan Capital | Maintained | Buy | $25.00 |
| Aug 12, 2025 | Roth Capital | Maintained | Buy | $38.00 |
| Aug 1, 2025 | Chardan Capital | Maintained | Buy | $25.00 |
| Jul 3, 2025 | Chardan Capital | Maintained | Buy | $25.00 |
| May 9, 2025 | Barclays | Maintained | Overweight | $38.00 |

## Frequently Asked Questions

### What is the price target for FDMT stock?

The average 12-month analyst price target for 4D Molecular (FDMT) is $30.20, with a high estimate of $37.00 and a low of $20.00, across 5 analysts.

### Is FDMT a buy, sell, or hold?

Analysts covering 4D Molecular currently average a Buy rating: 11 buy, 1 hold and 0 sell, from 12 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for FDMT?

The average price target of $30.20 implies 134.65% upside from the last price of $12.87.

### What is the latest analyst rating on FDMT?

On Oct 6, 2026, Chardan Capital maintained 4D Molecular at Buy with a price target of $25.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).